HB0417
Criminal Law - Schedule III Controlled Dangerous Substances - Medetomidine and Xylazine
Prohibiting a retailer from distributing, selling, or exposing for sale a medetomidine product or xylazine product unless the purchaser provides proof the intended use is for institutional, veterinary, or scientific purposes; prohibiting a retailer from distributing, selling, or exposing for sale a medetomidine or xylazine product to an individual under the age of 21 years; requiring a retailer that prepares, distributes, sells, or exposes for sale a medetomidine or xylazine product to maintain certain records; etc.
Basic Information
- Status
- Enrolled
- Session
- 2026 Regular Session
- Type
- Unknown
- Cross-filed
- SB0435
Links
- State Link
- View on State Website
- LegiScan URL
- View on LegiScan
Upcoming Events
Hearing
February 10, 2026
at 14:00
📍 Health
Hearing - Health Committee
Hearing
February 10, 2026
at 14:30
📍 Health
Hearing - Health Committee
Sponsors
Alston
Bagnall
Cullison
Guzzone
Lopez
Martinez
Morgan, M.
White Holland
Woorman
Hill
Reilly
Rosenberg
Szeliga
Taveras
Pippy
Kerr
Hutchinson
Johnson, S.
Kaufman
Kipke
Ross